Glide Pharma

Glide Pharmaceutical Technologies is a clinical-stage development company focused on solid-dose formulations for therapeutics and vaccines. The company has developed SDI, a solid-dose injector system, to improve patient adherence to self-administered long-term treatments. Its solid-dose formulations include octreotide, teriparatide, anthrax, and influenza vaccines.